We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > VZV

News List

NASA calls for new vaccinations to combat virus reactivation during spaceflight pharmaceutical-technology
March 19, 2019
Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination, to ensure the success of deep-space missions.
NanoViricides Reaches Agreement on Terms of License for Shingles Virus Drug Development americanpharmaceuticalreview
February 27, 2019
NanoViricides has reached an agreement on the terms of the license for the drug development against VZV, the virus that causes chickenpox in children and shingles in adults....